Suppr超能文献

糖尿病对慢性丙型肝炎患者循环凋亡微粒的影响。

Influence of Diabetes on Circulating Apoptotic Microparticles in Patients with Chronic Hepatitis C.

作者信息

Zuwala-Jagiello Jolanta, Pazgan-Simon Monika, Murawska-Cialowicz Eugenia, Simon Krzysztof

机构信息

Department of Pharmaceutical Biochemistry, Wroclaw Medical University, Wroclaw, Poland

Infectious Disease Department, Division of Infectious Disease and Hepatology Wroclaw Medical University, Wroclaw, Poland.

出版信息

In Vivo. 2017 Sep-Oct;31(5):1027-1034. doi: 10.21873/invivo.11165.

Abstract

BACKGROUND/AIM: Type 2 diabetes mellitus (DM) frequently occurs in patients with chronic hepatitis C (CHC) and is associated with atherosclerosis, in which circulating microparticles (MPs) play an important role. We asked whether the presence of DM affects endothelial-derived (EMPs) and platelet-derived microparticles (PMPs) levels; and whether MPs levels associate with biomarkers of inflammation and oxidative stress in patients with CHC.

MATERIALS AND METHODS

Overall, 136 patients were enrolled in the study, 86 CHC patients (41 with DM with moderate glycemic control), 20 outpatients with DM and 30 controls. Circulating MPs were phenotyped by flow cytometry.

RESULTS

When the MPs levels were analyzed individually in CHC patients, there was a positive association of plasma apoptotic MPs with oxidative stress markers. We report a hitherto undescribed relationship between diabetes prevalence and apoptotic MPs-associated inflammation in patients with CHC.

CONCLUSION

The presence of apoptotic MPs in the plasma of CHC patients, with increased levels being found in patients with DM and moderate glycemic control was herein demonstrated. The simultaneous monitoring of plasma apoptotic MPs, oxidative stress markers and inflammatory biomarkers can be helpful for the cardiovascular disease control in diabetic patients with CHC.

摘要

背景/目的:2型糖尿病(DM)在慢性丙型肝炎(CHC)患者中频繁发生,且与动脉粥样硬化相关,循环微粒(MPs)在其中起重要作用。我们探讨DM的存在是否会影响内皮细胞衍生微粒(EMPs)和血小板衍生微粒(PMPs)水平;以及MPs水平是否与CHC患者的炎症和氧化应激生物标志物相关。

材料与方法

本研究共纳入136例患者,其中86例CHC患者(41例DM患者且血糖控制适度),20例DM门诊患者和30例对照。通过流式细胞术对循环MPs进行表型分析。

结果

在CHC患者中单独分析MPs水平时,血浆凋亡MPs与氧化应激标志物呈正相关。我们报道了CHC患者中糖尿病患病率与凋亡MPs相关炎症之间一种迄今未描述的关系。

结论

本文证实CHC患者血浆中存在凋亡MPs,且在DM及血糖控制适度的患者中水平升高。同时监测血浆凋亡MPs、氧化应激标志物和炎症生物标志物有助于控制CHC糖尿病患者的心血管疾病。

相似文献

1
Influence of Diabetes on Circulating Apoptotic Microparticles in Patients with Chronic Hepatitis C.
In Vivo. 2017 Sep-Oct;31(5):1027-1034. doi: 10.21873/invivo.11165.
2
Effects of lipid-lowering treatment on circulating microparticles in patients with diabetes mellitus and chronic kidney disease.
Nephrol Dial Transplant. 2016 Jun;31(6):944-52. doi: 10.1093/ndt/gfv337. Epub 2015 Sep 22.
5
Microparticles as new markers of cardiovascular risk in diabetes and beyond.
Thromb Haemost. 2016 Aug 1;116(2):220-34. doi: 10.1160/TH16-03-0176. Epub 2016 May 12.
6
Meal intake increases circulating procoagulant microparticles in patients with type 1 and type 2 diabetes mellitus.
Platelets. 2019;30(3):348-355. doi: 10.1080/09537104.2018.1445837. Epub 2018 Mar 16.
7
Plasma microparticles in Alzheimer's disease: The role of vascular dysfunction.
Metab Brain Dis. 2018 Feb;33(1):293-299. doi: 10.1007/s11011-017-0149-3. Epub 2017 Dec 5.
8
Role of microparticles derived from monocytes, endothelial cells and platelets in the exacerbation of COPD.
Int J Chron Obstruct Pulmon Dis. 2018 Nov 15;13:3749-3757. doi: 10.2147/COPD.S175607. eCollection 2018.
9
The pattern of circulating microparticles in patients with diabetes mellitus with asymptomatic atherosclerosis.
Acta Clin Belg. 2016 Feb;71(1):38-45. doi: 10.1080/17843286.2015.1110894. Epub 2016 Feb 3.
10

引用本文的文献

1
Extracellular vesicles arising from apoptosis: forms, functions, and applications.
J Pathol. 2023 Aug;260(5):592-608. doi: 10.1002/path.6138. Epub 2023 Jun 9.
2
Platelet Microparticle Controversial Role in Cancer.
Adv Pharm Bull. 2021 Jan;11(1):39-55. doi: 10.34172/apb.2021.005. Epub 2020 Nov 7.

本文引用的文献

1
Elevated circulating endothelial cell-derived microparticle levels in patients with liver cirrhosis: a preliminary report.
Clin Exp Hepatol. 2015 Nov;1(3):105-111. doi: 10.5114/ceh.2015.55567. Epub 2015 Nov 16.
2
Thrombosis formation on atherosclerotic lesions and plaque rupture.
J Intern Med. 2014 Dec;276(6):618-32. doi: 10.1111/joim.12296. Epub 2014 Sep 25.
3
Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets.
Acta Pharmacol Sin. 2014 Apr;35(4):433-43. doi: 10.1038/aps.2013.188. Epub 2014 Mar 10.
4
High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation.
Cardiovasc Res. 2013 Apr 1;98(1):94-106. doi: 10.1093/cvr/cvt013. Epub 2013 Jan 22.
5
Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques.
Thromb Haemost. 2012 Dec;108(6):1208-19. doi: 10.1160/TH12-07-0486. Epub 2012 Nov 8.
8
Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study.
J Viral Hepat. 2012 Apr;19(4):271-7. doi: 10.1111/j.1365-2893.2011.01545.x. Epub 2011 Nov 13.
9
Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis.
Atherosclerosis. 2012 Apr;221(2):496-502. doi: 10.1016/j.atherosclerosis.2012.01.051. Epub 2012 Feb 8.
10
Microvesicles and viral infection.
J Virol. 2011 Dec;85(24):12844-54. doi: 10.1128/JVI.05853-11. Epub 2011 Oct 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验